RxDoctor Payments Data

Pierce Nunley, MD

Orthopaedic Surgery · Shreveport, LANPI 1417940750

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,487,441 of the $1,843,452 with a category attached, or 80.7%. 40 manufacturers reported payments, led by Stryker at 57.0% of the total. Among orthopaedic surgery clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,843,452in general payments, 2019–2025

Across 353 payments — averaging $5222.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1.1M
  • VB Spine LLC$153K
  • Spineology Inc.$98K
  • Philadelphia Medical Management Company LLC$91K
  • Zimmer Biomet$85K
  • The Institute Of Musculoskeletal Science And Education$83K
  • plus $284K from 34 others
$2,190,140in research payments, 2019–2025

Across 543 payments — averaging $4033.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Centinel Spine, LLC$651K
  • Providence Medical Technology, Inc.$479K
  • Spineology Inc.$299K
  • Globus Medical$268K
  • Pfizer$137K
  • Intrinsic Therapeutics$131K
  • plus $223K from 8 others
$238in ownership & investment interests, 2019–2025

Across 7 payments — averaging $33.93 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spineology Inc.$238

What the payments were for

  • Royalty or licence$1,487,44181%
  • Consulting fees$234,44013%
  • Speaking & faculty fees$57,9513%
  • Travel & lodging$46,3423%
  • Food & beverage$16,5871%
  • Gifts$6910%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,843,452 in reported general payments places this provider in the 95th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$336,535
Medicare patients
407
Services billed
3,027

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Alprazolam11$6

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →